MTOR and autosomal dominant polycystic kidney disease: Dysregulation of the mTOR pathway has not only been implicated in ADPKD, but in a number of other renal cystic disorders such as ARPKD [47] and several rodent models with mutations in other cystoprotein genes [17], [48].